Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV-HIV Coinfected Liver Transplant RecipientsTERRAULT, N; REDDY, K. R; SCHIFF, E et al.American journal of transplantation (Print). 2014, Vol 14, Num 5, pp 1129-1135, issn 1600-6135, 7 p.Article

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteersGUIMARAES-WALKER, A; MACKIE, N; BABIKER, A et al.Vaccine. 2008, Vol 26, Num 51, pp 6671-6677, issn 0264-410X, 7 p.Article

Reduction of HIV Persistence Following Transplantation in HIV-Infected Kidney Transplant RecipientsSTOCK, P. G; BARIN, B; HATANO, H et al.American journal of transplantation (Print). 2014, Vol 14, Num 5, pp 1136-1141, issn 1600-6135, 6 p.Article

HIV-Infected Liver and Kidney Transplant Recipients: 1-and 3-Year OutcomesROLAND, M. E; BARIN, B; MURPHY, B et al.American journal of transplantation (Print). 2008, Vol 8, Num 2, pp 355-365, issn 1600-6135, 11 p.Article